KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Working Capital Changes (2021 - 2023)

Historic Other Working Capital Changes for BioNTech SE (BNTX) over the last 3 years, with Q1 2023 value amounting to $86.1 million.

  • BioNTech SE's Other Working Capital Changes fell 1477.9% to $86.1 million in Q1 2023 from the same period last year, while for Mar 2023 it was $86.1 million, marking a year-over-year decrease of 1477.9%. This contributed to the annual value of $24.9 million for FY2022, which is 7582.1% down from last year.
  • As of Q1 2023, BioNTech SE's Other Working Capital Changes stood at $86.1 million, which was down 1477.9% from $24.9 million recorded in Q4 2022.
  • Over the past 5 years, BioNTech SE's Other Working Capital Changes peaked at $103.0 million during Q4 2021, and registered a low of $24.9 million during Q4 2022.
  • In the last 3 years, BioNTech SE's Other Working Capital Changes had a median value of $93.5 million in 2022 and averaged $78.7 million.
  • Per our database at Business Quant, BioNTech SE's Other Working Capital Changes plummeted by 7582.1% in 2022 and then plummeted by 1477.9% in 2023.
  • BioNTech SE's Other Working Capital Changes (Quarter) stood at $103.0 million in 2021, then crashed by 75.82% to $24.9 million in 2022, then soared by 245.79% to $86.1 million in 2023.
  • Its last three reported values are $86.1 million in Q1 2023, $24.9 million for Q4 2022, and $101.0 million during Q1 2022.